IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.251
EU - Europa 3.856
AS - Asia 2.215
SA - Sud America 467
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 10.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.125
IE - Irlanda 1.083
SG - Singapore 699
DE - Germania 685
SE - Svezia 550
CN - Cina 531
HK - Hong Kong 434
UA - Ucraina 415
BR - Brasile 373
IT - Italia 326
FI - Finlandia 260
RU - Federazione Russa 259
VN - Vietnam 219
IN - India 128
CA - Canada 92
GB - Regno Unito 90
FR - Francia 61
AR - Argentina 38
IR - Iran 36
KR - Corea 34
PL - Polonia 31
BJ - Benin 30
ID - Indonesia 28
MX - Messico 27
BD - Bangladesh 24
BE - Belgio 22
JP - Giappone 20
TR - Turchia 19
EC - Ecuador 17
ZA - Sudafrica 17
ES - Italia 16
LT - Lituania 14
AT - Austria 11
NL - Olanda 10
PY - Paraguay 10
EG - Egitto 9
UZ - Uzbekistan 9
EU - Europa 8
RO - Romania 8
CL - Cile 7
CO - Colombia 7
VE - Venezuela 7
AL - Albania 5
IQ - Iraq 5
MA - Marocco 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
IL - Israele 3
PE - Perù 3
PK - Pakistan 3
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 10.870
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
Jacksonville 747
Hong Kong 433
Dearborn 412
Singapore 271
Beijing 261
Ashburn 246
Chandler 217
New York 217
Wilmington 186
Ann Arbor 146
Lawrence 134
Princeton 134
Los Angeles 129
Piemonte 104
Moscow 99
San Mateo 90
Andover 84
Munich 83
Ho Chi Minh City 80
Buffalo 68
Toronto 53
Bremen 50
Grafing 49
São Paulo 45
Hanoi 41
Novara 40
Seoul 34
Redondo Beach 32
Santa Clara 32
Dallas 31
Cotonou 30
Helsinki 27
Frankfurt am Main 26
Denver 22
Stockholm 22
Leawood 21
Warsaw 21
Atlanta 20
Brussels 20
Montreal 20
Orem 20
Tokyo 20
Cave Creek 19
Hefei 19
Houston 19
London 19
Nanjing 19
Brooklyn 18
Monmouth Junction 18
Woodbridge 18
Zanjan 18
Boardman 15
Kunming 15
Norwalk 15
Nuremberg 14
Rio de Janeiro 14
Chicago 13
Mexico City 13
Biên Hòa 12
Kocaeli 11
Poplar 11
Seattle 11
Augusta 10
Chennai 10
Guangzhou 10
Jinan 10
Manchester 10
Mumbai 10
Turku 10
Ardabil 9
Bexley 9
Boston 9
Fairfield 9
Haiphong 9
Jakarta 9
Johannesburg 9
Milan 9
Turin 9
Da Nang 8
Hebei 8
Phoenix 8
Tashkent 8
Wroclaw 8
Ankara 7
Belo Horizonte 7
Campinas 7
Curitiba 7
Ninh Bình 7
San Francisco 7
Tianjin 7
Udine 7
Vienna 7
Wuhan 7
Cairo 6
Fortaleza 6
Hải Dương 6
Mülheim 6
Quito 6
Sacramento 6
Totale 6.500
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 134
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 126
Transition metal carbonyl clusters in biology: A futile or niche research area? 122
195Pt NMR chemical shift: a chemometric approach 121
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 119
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 116
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 115
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 115
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 114
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 114
Different strategies to exploit Pt(IV) complexes as pro-drugs 113
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 110
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 108
A different way for the oxidation of the Pt(II) complexes 108
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 107
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 105
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 105
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 101
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 101
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 101
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 101
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 101
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 99
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 99
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 99
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 98
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 97
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 96
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 96
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 96
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 93
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 93
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 93
A view on multi-action Pt(IV) antitumor prodrugs 93
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 92
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 92
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 92
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 91
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 89
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 89
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 88
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 88
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 88
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 87
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 87
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 86
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 86
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 85
Pt-195 NMR spectroscopy: A chemometric approach 85
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 85
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 85
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 84
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 84
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 83
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 83
Pt(IV) complexes as anticancer prodrugs 83
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 83
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 82
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 82
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 82
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 81
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 81
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 79
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 79
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 79
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 78
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 78
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 77
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 76
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 75
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 75
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 73
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 72
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 71
Experimental determination and modeling of the lipophilicity in platinum complexes 70
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 70
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 69
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 69
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 68
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 67
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 67
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 67
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 66
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 66
Targeting and delivery of Pt(II) antiproliferative drugs 65
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 65
Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex? 65
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 65
Ethynylestradiol-Pt(II) complexes for selective drug targeting 64
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 62
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 62
Platinum Complexes With Substituted Phosphines: Synthesis, Characterization, And Antiproliferative Activity 61
Inhibition of STAT3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line 61
Synthesis and characterization of a series of Pt(IV) complexes: relationship between cytotoxicity and physico-chemical parameters 60
New Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural studies and in vitro antitumor activity 60
Nano-vectors for targeting and delivery of Pt-based anti-tumor drugs 59
In Vitro And In Vivo Activity Of A New Platinum Nanoparticulate Coniugate 59
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 59
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases 58
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 57
Totale 8.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021525 0 0 0 0 0 27 141 4 150 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.397 16 49 88 25 70 94 158 82 312 156 73 274
2025/20262.623 338 276 470 941 553 45 0 0 0 0 0 0
Totale 11.049